Search for company
Explore more than 1.3 million company profiles from emerging markets

Pharmicell Co.,Ltd. (Korea)

Main Activities: Chemical Manufacturing
Quote Chart
Quote Summary
Last Price 4,140.00
Volume 1,950,876
Turnover 7,964,451,270
Market EXCH
Ticker 5690
Market Cap Market Cap 221,305,120
52 Week High 5,120.00
52 Week Low 2,810.00
Dividend Yield
Enterprise Value
Quote updated on March 27, 2015
Note: data in KRW Thousands.
Select Items to chart them. 2014 H1
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets 102,148,695
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Individual
Source: Korea Information Service (KIS), EMIS Company Database.
Company Description

The firm has the copyright of a stem cell drug of FCB-Pharmicell, and sales of bio pharmaceuticals rose, due to increase in demand expansion, and thus, firms biz revenue grew.Loss rose, because of selling and administrative expenses surpassing sales, as well as raw material price hike, that is the price of stem cell cultivation liquid.Negative cash flows from operating expenses continue, due to continued deficit, increase in inventories and repayment of some trade payables, and the firm appropriates working…

Main Products

Fashion /Trading/Men's Suit

Contact Information

120 Dosan-daero Gangnam-gu Seoul
Seoul; Seoul; Map
Postal Code: 135811
Tel: 02-3496-0114
Fax: 02-3496-0159

Full name: Pharmicell Co.,Ltd.

Previous name(s): FCB TWELVE CO.,LTD. (2011)

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
Incorporation Date: 20-Aug-68

Basic Information
Total Employees:
Outstanding Shares:
: ()
Registered Capital:
Financial Auditors:
Key Executives
Ownership Details
Kim, Hyeon Su
Affiliates and related companies
Yuhwa Japan
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Competitors - Korea

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.